Medical Care
Global Tumor Biomarker Test Market Research Report 2025
- Sep 09, 25
- ID: 494332
- Pages: 85
- Figures: 86
- Views: 14
This report aims to provide a comprehensive presentation of the global market for Tumor Biomarker Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Biomarker Test.
The Tumor Biomarker Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Biomarker Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Biomarker Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Segment by Type
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
Segment by Application
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Biomarker Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Tumor Biomarker Test market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Biomarker Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Biomarker Test companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories, Inc.
Agilent Technologies
AstraZeneca
Becton Dickinson & Co.
Biocept Inc.
Cancer Genetics Inc.
Danaher Corporation
Foundation Medicine Inc.
Illumina Inc.
LabCorp Of America Holdings
Luminex Corporation
Myriad Genetics Inc.
NanoString Technologies Inc.
Segment by Type
Prostate Specific Antigen Tests
CTC Tests
Alpha-Fetoprotein (AFP) Tests
CA Test
HER2 Tests
BRCA Test
Anaplastic Lymphoma Kinase (ALK) Tests
EGFR Mutation Tests
KRAS Test
Others
Segment by Application
Lung cancer
Breast cancer
Colorectal
Prostate Cancer
Blood Cancer
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Biomarker Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Biomarker Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prostate Specific Antigen Tests
1.2.3 CTC Tests
1.2.4 Alpha-Fetoprotein (AFP) Tests
1.2.5 CA Test
1.2.6 HER2 Tests
1.2.7 BRCA Test
1.2.8 Anaplastic Lymphoma Kinase (ALK) Tests
1.2.9 EGFR Mutation Tests
1.2.10 KRAS Test
1.3 Market by Application
1.3.1 Global Tumor Biomarker Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung cancer
1.3.3 Breast cancer
1.3.4 Colorectal
1.3.5 Prostate Cancer
1.3.6 Blood Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Biomarker Test Market Perspective (2020-2031)
2.2 Global Tumor Biomarker Test Growth Trends by Region
2.2.1 Global Tumor Biomarker Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Biomarker Test Historic Market Size by Region (2020-2025)
2.2.3 Tumor Biomarker Test Forecasted Market Size by Region (2026-2031)
2.3 Tumor Biomarker Test Market Dynamics
2.3.1 Tumor Biomarker Test Industry Trends
2.3.2 Tumor Biomarker Test Market Drivers
2.3.3 Tumor Biomarker Test Market Challenges
2.3.4 Tumor Biomarker Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Biomarker Test Players by Revenue
3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2020-2025)
3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Biomarker Test Revenue
3.4 Global Tumor Biomarker Test Market Concentration Ratio
3.4.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2024
3.5 Global Key Players of Tumor Biomarker Test Head office and Area Served
3.6 Global Key Players of Tumor Biomarker Test, Product and Application
3.7 Global Key Players of Tumor Biomarker Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Biomarker Test Breakdown Data by Type
4.1 Global Tumor Biomarker Test Historic Market Size by Type (2020-2025)
4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2026-2031)
5 Tumor Biomarker Test Breakdown Data by Application
5.1 Global Tumor Biomarker Test Historic Market Size by Application (2020-2025)
5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Biomarker Test Market Size (2020-2031)
6.2 North America Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Biomarker Test Market Size by Country (2020-2025)
6.4 North America Tumor Biomarker Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Biomarker Test Market Size (2020-2031)
7.2 Europe Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Biomarker Test Market Size by Country (2020-2025)
7.4 Europe Tumor Biomarker Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Biomarker Test Market Size (2020-2031)
8.2 Asia-Pacific Tumor Biomarker Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Biomarker Test Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Biomarker Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Biomarker Test Market Size (2020-2031)
9.2 Latin America Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Biomarker Test Market Size by Country (2020-2025)
9.4 Latin America Tumor Biomarker Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Biomarker Test Market Size (2020-2031)
10.2 Middle East & Africa Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Biomarker Test Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Biomarker Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Details
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Tumor Biomarker Test Introduction
11.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2020-2025)
11.2.5 Agilent Technologies Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Tumor Biomarker Test Introduction
11.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Becton Dickinson & Co.
11.4.1 Becton Dickinson & Co. Company Details
11.4.2 Becton Dickinson & Co. Business Overview
11.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction
11.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2020-2025)
11.4.5 Becton Dickinson & Co. Recent Development
11.5 Biocept Inc.
11.5.1 Biocept Inc. Company Details
11.5.2 Biocept Inc. Business Overview
11.5.3 Biocept Inc. Tumor Biomarker Test Introduction
11.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.5.5 Biocept Inc. Recent Development
11.6 Cancer Genetics Inc.
11.6.1 Cancer Genetics Inc. Company Details
11.6.2 Cancer Genetics Inc. Business Overview
11.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction
11.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.6.5 Cancer Genetics Inc. Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Tumor Biomarker Test Introduction
11.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2020-2025)
11.7.5 Danaher Corporation Recent Development
11.8 Foundation Medicine Inc.
11.8.1 Foundation Medicine Inc. Company Details
11.8.2 Foundation Medicine Inc. Business Overview
11.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction
11.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.8.5 Foundation Medicine Inc. Recent Development
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Details
11.9.2 Illumina Inc. Business Overview
11.9.3 Illumina Inc. Tumor Biomarker Test Introduction
11.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.9.5 Illumina Inc. Recent Development
11.10 LabCorp Of America Holdings
11.10.1 LabCorp Of America Holdings Company Details
11.10.2 LabCorp Of America Holdings Business Overview
11.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction
11.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2020-2025)
11.10.5 LabCorp Of America Holdings Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Tumor Biomarker Test Introduction
11.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
11.12 Myriad Genetics Inc.
11.12.1 Myriad Genetics Inc. Company Details
11.12.2 Myriad Genetics Inc. Business Overview
11.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction
11.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.12.5 Myriad Genetics Inc. Recent Development
11.13 NanoString Technologies Inc.
11.13.1 NanoString Technologies Inc. Company Details
11.13.2 NanoString Technologies Inc. Business Overview
11.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction
11.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.13.5 NanoString Technologies Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Biomarker Test Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prostate Specific Antigen Tests
1.2.3 CTC Tests
1.2.4 Alpha-Fetoprotein (AFP) Tests
1.2.5 CA Test
1.2.6 HER2 Tests
1.2.7 BRCA Test
1.2.8 Anaplastic Lymphoma Kinase (ALK) Tests
1.2.9 EGFR Mutation Tests
1.2.10 KRAS Test
1.3 Market by Application
1.3.1 Global Tumor Biomarker Test Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung cancer
1.3.3 Breast cancer
1.3.4 Colorectal
1.3.5 Prostate Cancer
1.3.6 Blood Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Biomarker Test Market Perspective (2020-2031)
2.2 Global Tumor Biomarker Test Growth Trends by Region
2.2.1 Global Tumor Biomarker Test Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Tumor Biomarker Test Historic Market Size by Region (2020-2025)
2.2.3 Tumor Biomarker Test Forecasted Market Size by Region (2026-2031)
2.3 Tumor Biomarker Test Market Dynamics
2.3.1 Tumor Biomarker Test Industry Trends
2.3.2 Tumor Biomarker Test Market Drivers
2.3.3 Tumor Biomarker Test Market Challenges
2.3.4 Tumor Biomarker Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Biomarker Test Players by Revenue
3.1.1 Global Top Tumor Biomarker Test Players by Revenue (2020-2025)
3.1.2 Global Tumor Biomarker Test Revenue Market Share by Players (2020-2025)
3.2 Global Tumor Biomarker Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Biomarker Test Revenue
3.4 Global Tumor Biomarker Test Market Concentration Ratio
3.4.1 Global Tumor Biomarker Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Biomarker Test Revenue in 2024
3.5 Global Key Players of Tumor Biomarker Test Head office and Area Served
3.6 Global Key Players of Tumor Biomarker Test, Product and Application
3.7 Global Key Players of Tumor Biomarker Test, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Biomarker Test Breakdown Data by Type
4.1 Global Tumor Biomarker Test Historic Market Size by Type (2020-2025)
4.2 Global Tumor Biomarker Test Forecasted Market Size by Type (2026-2031)
5 Tumor Biomarker Test Breakdown Data by Application
5.1 Global Tumor Biomarker Test Historic Market Size by Application (2020-2025)
5.2 Global Tumor Biomarker Test Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Tumor Biomarker Test Market Size (2020-2031)
6.2 North America Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Tumor Biomarker Test Market Size by Country (2020-2025)
6.4 North America Tumor Biomarker Test Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Biomarker Test Market Size (2020-2031)
7.2 Europe Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Tumor Biomarker Test Market Size by Country (2020-2025)
7.4 Europe Tumor Biomarker Test Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Biomarker Test Market Size (2020-2031)
8.2 Asia-Pacific Tumor Biomarker Test Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Tumor Biomarker Test Market Size by Region (2020-2025)
8.4 Asia-Pacific Tumor Biomarker Test Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Biomarker Test Market Size (2020-2031)
9.2 Latin America Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Tumor Biomarker Test Market Size by Country (2020-2025)
9.4 Latin America Tumor Biomarker Test Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Biomarker Test Market Size (2020-2031)
10.2 Middle East & Africa Tumor Biomarker Test Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Tumor Biomarker Test Market Size by Country (2020-2025)
10.4 Middle East & Africa Tumor Biomarker Test Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Details
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Tumor Biomarker Test Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.1.5 Abbott Laboratories, Inc. Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Tumor Biomarker Test Introduction
11.2.4 Agilent Technologies Revenue in Tumor Biomarker Test Business (2020-2025)
11.2.5 Agilent Technologies Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Tumor Biomarker Test Introduction
11.3.4 AstraZeneca Revenue in Tumor Biomarker Test Business (2020-2025)
11.3.5 AstraZeneca Recent Development
11.4 Becton Dickinson & Co.
11.4.1 Becton Dickinson & Co. Company Details
11.4.2 Becton Dickinson & Co. Business Overview
11.4.3 Becton Dickinson & Co. Tumor Biomarker Test Introduction
11.4.4 Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2020-2025)
11.4.5 Becton Dickinson & Co. Recent Development
11.5 Biocept Inc.
11.5.1 Biocept Inc. Company Details
11.5.2 Biocept Inc. Business Overview
11.5.3 Biocept Inc. Tumor Biomarker Test Introduction
11.5.4 Biocept Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.5.5 Biocept Inc. Recent Development
11.6 Cancer Genetics Inc.
11.6.1 Cancer Genetics Inc. Company Details
11.6.2 Cancer Genetics Inc. Business Overview
11.6.3 Cancer Genetics Inc. Tumor Biomarker Test Introduction
11.6.4 Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.6.5 Cancer Genetics Inc. Recent Development
11.7 Danaher Corporation
11.7.1 Danaher Corporation Company Details
11.7.2 Danaher Corporation Business Overview
11.7.3 Danaher Corporation Tumor Biomarker Test Introduction
11.7.4 Danaher Corporation Revenue in Tumor Biomarker Test Business (2020-2025)
11.7.5 Danaher Corporation Recent Development
11.8 Foundation Medicine Inc.
11.8.1 Foundation Medicine Inc. Company Details
11.8.2 Foundation Medicine Inc. Business Overview
11.8.3 Foundation Medicine Inc. Tumor Biomarker Test Introduction
11.8.4 Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.8.5 Foundation Medicine Inc. Recent Development
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Details
11.9.2 Illumina Inc. Business Overview
11.9.3 Illumina Inc. Tumor Biomarker Test Introduction
11.9.4 Illumina Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.9.5 Illumina Inc. Recent Development
11.10 LabCorp Of America Holdings
11.10.1 LabCorp Of America Holdings Company Details
11.10.2 LabCorp Of America Holdings Business Overview
11.10.3 LabCorp Of America Holdings Tumor Biomarker Test Introduction
11.10.4 LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2020-2025)
11.10.5 LabCorp Of America Holdings Recent Development
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Tumor Biomarker Test Introduction
11.11.4 Luminex Corporation Revenue in Tumor Biomarker Test Business (2020-2025)
11.11.5 Luminex Corporation Recent Development
11.12 Myriad Genetics Inc.
11.12.1 Myriad Genetics Inc. Company Details
11.12.2 Myriad Genetics Inc. Business Overview
11.12.3 Myriad Genetics Inc. Tumor Biomarker Test Introduction
11.12.4 Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.12.5 Myriad Genetics Inc. Recent Development
11.13 NanoString Technologies Inc.
11.13.1 NanoString Technologies Inc. Company Details
11.13.2 NanoString Technologies Inc. Business Overview
11.13.3 NanoString Technologies Inc. Tumor Biomarker Test Introduction
11.13.4 NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2020-2025)
11.13.5 NanoString Technologies Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prostate Specific Antigen Tests
Table 3. Key Players of CTC Tests
Table 4. Key Players of Alpha-Fetoprotein (AFP) Tests
Table 5. Key Players of CA Test
Table 6. Key Players of HER2 Tests
Table 7. Key Players of BRCA Test
Table 8. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests
Table 9. Global Tumor Biomarker Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Tumor Biomarker Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Tumor Biomarker Test Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Tumor Biomarker Test Market Share by Region (2020-2025)
Table 13. Global Tumor Biomarker Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Tumor Biomarker Test Market Share by Region (2026-2031)
Table 15. Tumor Biomarker Test Market Trends
Table 16. Tumor Biomarker Test Market Drivers
Table 17. Tumor Biomarker Test Market Challenges
Table 18. Tumor Biomarker Test Market Restraints
Table 19. Global Tumor Biomarker Test Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Tumor Biomarker Test Market Share by Players (2020-2025)
Table 21. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2024)
Table 22. Ranking of Global Top Tumor Biomarker Test Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Tumor Biomarker Test Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Tumor Biomarker Test, Headquarters and Area Served
Table 25. Global Key Players of Tumor Biomarker Test, Product and Application
Table 26. Global Key Players of Tumor Biomarker Test, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tumor Biomarker Test Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Tumor Biomarker Test Revenue Market Share by Type (2020-2025)
Table 30. Global Tumor Biomarker Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Tumor Biomarker Test Revenue Market Share by Type (2026-2031)
Table 32. Global Tumor Biomarker Test Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Tumor Biomarker Test Revenue Market Share by Application (2020-2025)
Table 34. Global Tumor Biomarker Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Tumor Biomarker Test Revenue Market Share by Application (2026-2031)
Table 36. North America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Tumor Biomarker Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Tumor Biomarker Test Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Tumor Biomarker Test Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Laboratories, Inc. Company Details
Table 52. Abbott Laboratories, Inc. Business Overview
Table 53. Abbott Laboratories, Inc. Tumor Biomarker Test Product
Table 54. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 55. Abbott Laboratories, Inc. Recent Development
Table 56. Agilent Technologies Company Details
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies Tumor Biomarker Test Product
Table 59. Agilent Technologies Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 60. Agilent Technologies Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Tumor Biomarker Test Product
Table 64. AstraZeneca Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Becton Dickinson & Co. Company Details
Table 67. Becton Dickinson & Co. Business Overview
Table 68. Becton Dickinson & Co. Tumor Biomarker Test Product
Table 69. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 70. Becton Dickinson & Co. Recent Development
Table 71. Biocept Inc. Company Details
Table 72. Biocept Inc. Business Overview
Table 73. Biocept Inc. Tumor Biomarker Test Product
Table 74. Biocept Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 75. Biocept Inc. Recent Development
Table 76. Cancer Genetics Inc. Company Details
Table 77. Cancer Genetics Inc. Business Overview
Table 78. Cancer Genetics Inc. Tumor Biomarker Test Product
Table 79. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 80. Cancer Genetics Inc. Recent Development
Table 81. Danaher Corporation Company Details
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Tumor Biomarker Test Product
Table 84. Danaher Corporation Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. Foundation Medicine Inc. Company Details
Table 87. Foundation Medicine Inc. Business Overview
Table 88. Foundation Medicine Inc. Tumor Biomarker Test Product
Table 89. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 90. Foundation Medicine Inc. Recent Development
Table 91. Illumina Inc. Company Details
Table 92. Illumina Inc. Business Overview
Table 93. Illumina Inc. Tumor Biomarker Test Product
Table 94. Illumina Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 95. Illumina Inc. Recent Development
Table 96. LabCorp Of America Holdings Company Details
Table 97. LabCorp Of America Holdings Business Overview
Table 98. LabCorp Of America Holdings Tumor Biomarker Test Product
Table 99. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 100. LabCorp Of America Holdings Recent Development
Table 101. Luminex Corporation Company Details
Table 102. Luminex Corporation Business Overview
Table 103. Luminex Corporation Tumor Biomarker Test Product
Table 104. Luminex Corporation Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 105. Luminex Corporation Recent Development
Table 106. Myriad Genetics Inc. Company Details
Table 107. Myriad Genetics Inc. Business Overview
Table 108. Myriad Genetics Inc. Tumor Biomarker Test Product
Table 109. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 110. Myriad Genetics Inc. Recent Development
Table 111. NanoString Technologies Inc. Company Details
Table 112. NanoString Technologies Inc. Business Overview
Table 113. NanoString Technologies Inc. Tumor Biomarker Test Product
Table 114. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 115. NanoString Technologies Inc. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Tumor Biomarker Test Picture
Figure 2. Global Tumor Biomarker Test Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Biomarker Test Market Share by Type: 2024 VS 2031
Figure 4. Prostate Specific Antigen Tests Features
Figure 5. CTC Tests Features
Figure 6. Alpha-Fetoprotein (AFP) Tests Features
Figure 7. CA Test Features
Figure 8. HER2 Tests Features
Figure 9. BRCA Test Features
Figure 10. Anaplastic Lymphoma Kinase (ALK) Tests Features
Figure 11. EGFR Mutation Tests Features
Figure 12. KRAS Test Features
Figure 13. Global Tumor Biomarker Test Market Size by Application (2020-2031) & (US$ Million)
Figure 14. Global Tumor Biomarker Test Market Share by Application: 2024 VS 2031
Figure 15. Lung cancer Case Studies
Figure 16. Breast cancer Case Studies
Figure 17. Colorectal Case Studies
Figure 18. Prostate Cancer Case Studies
Figure 19. Blood Cancer Case Studies
Figure 20. Tumor Biomarker Test Report Years Considered
Figure 21. Global Tumor Biomarker Test Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Tumor Biomarker Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Tumor Biomarker Test Market Share by Region: 2024 VS 2031
Figure 24. Global Tumor Biomarker Test Market Share by Players in 2024
Figure 25. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2024
Figure 27. North America Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 29. United States Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 33. Germany Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Tumor Biomarker Test Market Share by Region (2020-2031)
Figure 41. China Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 49. Mexico Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 53. Turkey Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 57. Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 59. Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 60. Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 61. Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 62. Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 63. Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 64. Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 65. LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 66. Luminex Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 67. Myriad Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 68. NanoString Technologies Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global Tumor Biomarker Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Prostate Specific Antigen Tests
Table 3. Key Players of CTC Tests
Table 4. Key Players of Alpha-Fetoprotein (AFP) Tests
Table 5. Key Players of CA Test
Table 6. Key Players of HER2 Tests
Table 7. Key Players of BRCA Test
Table 8. Key Players of Anaplastic Lymphoma Kinase (ALK) Tests
Table 9. Global Tumor Biomarker Test Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Tumor Biomarker Test Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Tumor Biomarker Test Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Tumor Biomarker Test Market Share by Region (2020-2025)
Table 13. Global Tumor Biomarker Test Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Tumor Biomarker Test Market Share by Region (2026-2031)
Table 15. Tumor Biomarker Test Market Trends
Table 16. Tumor Biomarker Test Market Drivers
Table 17. Tumor Biomarker Test Market Challenges
Table 18. Tumor Biomarker Test Market Restraints
Table 19. Global Tumor Biomarker Test Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Tumor Biomarker Test Market Share by Players (2020-2025)
Table 21. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2024)
Table 22. Ranking of Global Top Tumor Biomarker Test Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Tumor Biomarker Test Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Tumor Biomarker Test, Headquarters and Area Served
Table 25. Global Key Players of Tumor Biomarker Test, Product and Application
Table 26. Global Key Players of Tumor Biomarker Test, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Tumor Biomarker Test Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Tumor Biomarker Test Revenue Market Share by Type (2020-2025)
Table 30. Global Tumor Biomarker Test Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Tumor Biomarker Test Revenue Market Share by Type (2026-2031)
Table 32. Global Tumor Biomarker Test Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Tumor Biomarker Test Revenue Market Share by Application (2020-2025)
Table 34. Global Tumor Biomarker Test Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Tumor Biomarker Test Revenue Market Share by Application (2026-2031)
Table 36. North America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Tumor Biomarker Test Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Tumor Biomarker Test Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Tumor Biomarker Test Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Tumor Biomarker Test Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Tumor Biomarker Test Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Tumor Biomarker Test Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Laboratories, Inc. Company Details
Table 52. Abbott Laboratories, Inc. Business Overview
Table 53. Abbott Laboratories, Inc. Tumor Biomarker Test Product
Table 54. Abbott Laboratories, Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 55. Abbott Laboratories, Inc. Recent Development
Table 56. Agilent Technologies Company Details
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies Tumor Biomarker Test Product
Table 59. Agilent Technologies Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 60. Agilent Technologies Recent Development
Table 61. AstraZeneca Company Details
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Tumor Biomarker Test Product
Table 64. AstraZeneca Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. Becton Dickinson & Co. Company Details
Table 67. Becton Dickinson & Co. Business Overview
Table 68. Becton Dickinson & Co. Tumor Biomarker Test Product
Table 69. Becton Dickinson & Co. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 70. Becton Dickinson & Co. Recent Development
Table 71. Biocept Inc. Company Details
Table 72. Biocept Inc. Business Overview
Table 73. Biocept Inc. Tumor Biomarker Test Product
Table 74. Biocept Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 75. Biocept Inc. Recent Development
Table 76. Cancer Genetics Inc. Company Details
Table 77. Cancer Genetics Inc. Business Overview
Table 78. Cancer Genetics Inc. Tumor Biomarker Test Product
Table 79. Cancer Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 80. Cancer Genetics Inc. Recent Development
Table 81. Danaher Corporation Company Details
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Tumor Biomarker Test Product
Table 84. Danaher Corporation Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. Foundation Medicine Inc. Company Details
Table 87. Foundation Medicine Inc. Business Overview
Table 88. Foundation Medicine Inc. Tumor Biomarker Test Product
Table 89. Foundation Medicine Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 90. Foundation Medicine Inc. Recent Development
Table 91. Illumina Inc. Company Details
Table 92. Illumina Inc. Business Overview
Table 93. Illumina Inc. Tumor Biomarker Test Product
Table 94. Illumina Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 95. Illumina Inc. Recent Development
Table 96. LabCorp Of America Holdings Company Details
Table 97. LabCorp Of America Holdings Business Overview
Table 98. LabCorp Of America Holdings Tumor Biomarker Test Product
Table 99. LabCorp Of America Holdings Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 100. LabCorp Of America Holdings Recent Development
Table 101. Luminex Corporation Company Details
Table 102. Luminex Corporation Business Overview
Table 103. Luminex Corporation Tumor Biomarker Test Product
Table 104. Luminex Corporation Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 105. Luminex Corporation Recent Development
Table 106. Myriad Genetics Inc. Company Details
Table 107. Myriad Genetics Inc. Business Overview
Table 108. Myriad Genetics Inc. Tumor Biomarker Test Product
Table 109. Myriad Genetics Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 110. Myriad Genetics Inc. Recent Development
Table 111. NanoString Technologies Inc. Company Details
Table 112. NanoString Technologies Inc. Business Overview
Table 113. NanoString Technologies Inc. Tumor Biomarker Test Product
Table 114. NanoString Technologies Inc. Revenue in Tumor Biomarker Test Business (2020-2025) & (US$ Million)
Table 115. NanoString Technologies Inc. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Tumor Biomarker Test Picture
Figure 2. Global Tumor Biomarker Test Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Biomarker Test Market Share by Type: 2024 VS 2031
Figure 4. Prostate Specific Antigen Tests Features
Figure 5. CTC Tests Features
Figure 6. Alpha-Fetoprotein (AFP) Tests Features
Figure 7. CA Test Features
Figure 8. HER2 Tests Features
Figure 9. BRCA Test Features
Figure 10. Anaplastic Lymphoma Kinase (ALK) Tests Features
Figure 11. EGFR Mutation Tests Features
Figure 12. KRAS Test Features
Figure 13. Global Tumor Biomarker Test Market Size by Application (2020-2031) & (US$ Million)
Figure 14. Global Tumor Biomarker Test Market Share by Application: 2024 VS 2031
Figure 15. Lung cancer Case Studies
Figure 16. Breast cancer Case Studies
Figure 17. Colorectal Case Studies
Figure 18. Prostate Cancer Case Studies
Figure 19. Blood Cancer Case Studies
Figure 20. Tumor Biomarker Test Report Years Considered
Figure 21. Global Tumor Biomarker Test Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 22. Global Tumor Biomarker Test Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 23. Global Tumor Biomarker Test Market Share by Region: 2024 VS 2031
Figure 24. Global Tumor Biomarker Test Market Share by Players in 2024
Figure 25. Global Top Tumor Biomarker Test Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Biomarker Test as of 2024)
Figure 26. The Top 10 and 5 Players Market Share by Tumor Biomarker Test Revenue in 2024
Figure 27. North America Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. North America Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 29. United States Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Canada Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Europe Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Europe Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 33. Germany Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. France Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. U.K. Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Italy Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Russia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Nordic Countries Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Tumor Biomarker Test Market Share by Region (2020-2031)
Figure 41. China Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Japan Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. South Korea Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. India Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Australia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Latin America Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Latin America Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 49. Mexico Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Brazil Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Middle East & Africa Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Middle East & Africa Tumor Biomarker Test Market Share by Country (2020-2031)
Figure 53. Turkey Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 55. UAE Tumor Biomarker Test Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 56. Abbott Laboratories, Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 57. Agilent Technologies Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 58. AstraZeneca Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 59. Becton Dickinson & Co. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 60. Biocept Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 61. Cancer Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 62. Danaher Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 63. Foundation Medicine Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 64. Illumina Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 65. LabCorp Of America Holdings Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 66. Luminex Corporation Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 67. Myriad Genetics Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 68. NanoString Technologies Inc. Revenue Growth Rate in Tumor Biomarker Test Business (2020-2025)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232